Lapatinib in Stage IV Melanoma With ERBB4 Mutations
Clinical trial NCT01264081 · TERMINATED
Trial details
- NCT number
- NCT01264081
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-20
- Primary completion
- 2013-11-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.